The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Next post
Goodnight, sweet B.
Related posts
Is Jensen Huang’s job on the line? Yale’s Jeffrey Sonnenfeld estimates it’s “about a 50-50” | TechCrunch
techcrunch.com
Flock, maker of controversial license plate readers, starts to give campaign cash to local politicians
reddit.com
A Truck Demanding EA ‘Save Mass Effect’ Is Currently Driving Around The Company’s Headquarters
reddit.com
